{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:28Z","timestamp":1740107608382,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["SPHeRE\/2013\/1","(RL-15-1579)"],"award-info":[{"award-number":["SPHeRE\/2013\/1","(RL-15-1579)"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00592-020-01497-6","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:03:41Z","timestamp":1583172221000},"page":"875-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-0591","authenticated-orcid":false,"given":"Katarzyna Anna","family":"Gajewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5532-0242","authenticated-orcid":false,"given":"Regien","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-7665","authenticated-orcid":false,"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-2612","authenticated-orcid":false,"given":"Seamus","family":"Sreenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"issue":"Suppl 27","key":"1497_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/pedi.12731","volume":"19","author":"JL Sherr","year":"2018","unstructured":"Sherr JL, Tauschmann M, Battelino T et al (2018) ISPAD clinical practice consensus guidelines 2018: diabetes technologies. Pediatr Diabetes 19(Suppl 27):302\u2013325. https:\/\/doi.org\/10.1111\/pedi.12731","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"1497_CR2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2337\/dc14-1140","volume":"37","author":"JL Chiang","year":"2014","unstructured":"Chiang JL, Kirkman MS, Laffel LMB, Peters AL (2014) Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 37(7):2034\u20132054. https:\/\/doi.org\/10.2337\/dc14-1140","journal-title":"Diabetes Care"},{"issue":"11","key":"1497_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14110","volume":"14","author":"E Cummins","year":"2010","unstructured":"Cummins E, Royle P, Snaith A et al (2010) Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 14(11):1. https:\/\/doi.org\/10.3310\/hta14110","journal-title":"Health Technol Assess"},{"issue":"4","key":"1497_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4274\/jcrpe.0053","volume":"10","author":"Y Qin","year":"2018","unstructured":"Qin Y, Yang LH, Huang XL, Chen XH, Yao H (2018) Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: a Meta-Analysis of Randomized Control Trials. J Clin Res Pediatr Endocrinol 10(4):316\u2013323. https:\/\/doi.org\/10.4274\/jcrpe.0053","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"1497_CR5","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2337\/dc07-9922","volume":"30","author":"M Phillip","year":"2007","unstructured":"Phillip M, Battelino T, Rodriguez H et al (2007) Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30(6):1653\u20131662. https:\/\/doi.org\/10.2337\/dc07-9922","journal-title":"Diabetes Care"},{"issue":"3","key":"1497_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00592-015-0810-4","volume":"53","author":"R Bonfanti","year":"2016","unstructured":"Bonfanti R, Lepore G, Bozzetto L et al (2016) Survey on the use of insulin pumps in Italy: comparison between pediatric and adult age groups (IMITA study). Acta Diabetol 53(3):403\u2013412. https:\/\/doi.org\/10.1007\/s00592-015-0810-4","journal-title":"Acta Diabetol"},{"issue":"4","key":"1497_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2337\/dc18-1850","volume":"42","author":"E Toresson Grip","year":"2019","unstructured":"Toresson Grip E, Svensson AM, Miftaraj M et al (2019) Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes: a population-based and propensity-matched cohort from the Swedish National Diabetes Register. Diabetes Care 42(4):545\u2013552. https:\/\/doi.org\/10.2337\/dc18-1850","journal-title":"Diabetes Care"},{"key":"1497_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/pedi.12184","volume":"15","author":"T Danne","year":"2014","unstructured":"Danne T, Bangstad HJ, Deeb L et al (2014) Insulin treatment in children and adolescents with diabetes. Pediatric Diabetes 15:115\u2013134. https:\/\/doi.org\/10.1111\/pedi.12184","journal-title":"Pediatric Diabetes"},{"key":"1497_CR9","doi-asserted-by":"publisher","first-page":"j1285","DOI":"10.1136\/bmj.j1285","volume":"356","author":"Repose Study Group","year":"2017","unstructured":"Repose Study Group (2017) Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ 356:j1285. https:\/\/doi.org\/10.1136\/bmj.j1285","journal-title":"BMJ"},{"issue":"11","key":"1497_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/dme.12792","volume":"32","author":"S Roze","year":"2015","unstructured":"Roze S, Smith-Palmer J, Valentine W, de Portu S, Norgaard K, Pickup JC (2015) Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type1 diabetes: a systematic review. Diabetic Med 32(11):1415\u20131424. https:\/\/doi.org\/10.1111\/dme.12792","journal-title":"Diabetic Med"},{"issue":"7","key":"1497_CR11","first-page":"A348","volume":"17","author":"S Roze","year":"2014","unstructured":"Roze S, Cook M, Jethwa M, de Portu S (2014) Projection of long term health-economic benefits of sensor augmented pump (SAP) versus Pump Therapy Alone (CSII) in Type 1 Diabetes, a UK Perspective. Value Health 17(7):A348\u2013A348","journal-title":"Value Health"},{"key":"1497_CR12","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0888","author":"J \u0160oupal","year":"2019","unstructured":"\u0160oupal J, Petru\u017eelkov\u00e1 L, Grunberger G et al (2019) Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3\u00a0years of follow-up from the COMISAIR study. Diabetes Care. https:\/\/doi.org\/10.2337\/dc19-0888","journal-title":"Diabetes Care"},{"issue":"3","key":"1497_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/dia.2018.0328","volume":"21","author":"J Jendle","year":"2019","unstructured":"Jendle J, Pohlmann J, de Portu S, Smith-Palmer J, Roze S (2019) Cost-effectiveness analysis of the MiniMed 670G hybrid closed-loop system versus continuous subcutaneous insulin infusion for treatment of type 1 diabetes. Diabetes Technol Ther 21(3):110\u2013118. https:\/\/doi.org\/10.1089\/dia.2018.0328","journal-title":"Diabetes Technol Ther"},{"key":"1497_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13912","author":"SH Duffus","year":"2019","unstructured":"Duffus SH, Ta\u2019ani ZA, Slaughter JC, Niswender KD, Gregory JM (2019) Increased proportion of time in hybrid closed-loop \u201cAuto Mode\u201d is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.13912","journal-title":"Diabetes Obes Metab"},{"unstructured":"Diabetes Technology Network UK (2018) Best Practie Guide: Continuous subcutaneous insulin infusion (CSII). A clinical guide for adult diabetes services","key":"1497_CR15"},{"key":"1497_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.diabres.2018.04.042","volume":"141","author":"U Kampmann","year":"2018","unstructured":"Kampmann U, Madsen LR, Bjerg L et al (2018) Prevalence and geographical distribution of insulin pump therapy in the Central Denmark Region and its association with metabolic parameters. Diabetes Res Clin Pract 141:148\u2013155. https:\/\/doi.org\/10.1016\/j.diabres.2018.04.042","journal-title":"Diabetes Res Clin Pract"},{"key":"1497_CR17","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/S0168-8227(06)70016-X","volume":"74","author":"D Bruttomesso","year":"2006","unstructured":"Bruttomesso D, Costar S, Crazzolara D, Di Bartolo P, Girelli A, Tiengo A (2006) Continuous subcutaneous insulin infusion (CSII) in Italy. Diabetes Res Clin Pract 74:S130\u2013S134. https:\/\/doi.org\/10.1016\/S0168-8227(06)70016-X","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"1497_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1464-5491.2011.03517.x","volume":"29","author":"BM Carlsson","year":"2012","unstructured":"Carlsson BM, Andersson PN, Alnervik J, Carstensen J, Lind M (2012) Availability of insulin pump therapy in clinical practice. Diabet Med 29(8):1055\u20131059. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03517.x","journal-title":"Diabet Med"},{"unstructured":"Association of British Clinical Diabetologists, Diabetes UK JDRF, Diabetologists AoBC (2013) The United Kingdom Insulin Pump Audit\u2014Service Level Data","key":"1497_CR19"},{"key":"1497_CR20","first-page":"S227","volume":"188","author":"K Gajewska","year":"2019","unstructured":"Gajewska K, Biesma R, Bennett K, Sreenan S (2019) Barriers to accessing insulin pump therapy by adults with type 1 diabetes in Ireland: initial findings from a qualitative study. Ir J Med Sci 188:S227","journal-title":"Ir J Med Sci"},{"unstructured":"Percentage of Population Covered by Private Health Insurance (2018) https:\/\/health.gov.ie\/publications-research\/statistics\/statistics-by-topic\/private-health-insurance\/. Accessed 9 Aug 2019","key":"1497_CR21"},{"unstructured":"Gueret M (2016) Irish Medical Directory 2015\u20132016. The doctor's book, 22 edn., Dublin","key":"1497_CR22"},{"issue":"4","key":"1497_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/dme.12325","volume":"31","author":"HD White","year":"2014","unstructured":"White HD, Goenka N, Furlong NJ et al (2014) The U.K. service level audit of insulin pump therapy in adults. Diabet Med 31(4):412\u2013418. https:\/\/doi.org\/10.1111\/dme.12325","journal-title":"Diabet Med"},{"issue":"2","key":"1497_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/dia.2014.0242","volume":"17","author":"D Bruttomesso","year":"2015","unstructured":"Bruttomesso D, Laviola L, Lepore G et al (2015) Continuous subcutaneous insulin infusion in Italy: third national survey. Diabetes Technol Ther 17(2):96\u2013104. https:\/\/doi.org\/10.1089\/dia.2014.0242","journal-title":"Diabetes Technol Ther"},{"key":"1497_CR25","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0345","author":"L van den Boom","year":"2019","unstructured":"van den Boom L, Karges B, Auzanneau M et al (2019) Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care. https:\/\/doi.org\/10.2337\/dc19-0345","journal-title":"Diabetes Care"},{"unstructured":"Healthcare Quality Improvement Partnership (2018) National diabetes insulin pump audit report, Main Report, 2016\u20132017. Government Statistical Service","key":"1497_CR26"},{"issue":"1","key":"1497_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/dia.2009.0189","volume":"12","author":"E Renard","year":"2010","unstructured":"Renard E (2010) Insulin pump use in Europe. Diabetes Technol Ther 12(1):29\u201332","journal-title":"Diabetes Technol Ther"},{"key":"1497_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/dc15-0078\/-\/DC1","volume":"38","author":"KM Miller","year":"2015","unstructured":"Miller KM, Foster NC, Beck RW et al (2015) Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care 38:971\u2013978. https:\/\/doi.org\/10.2337\/dc15-0078\/-\/DC1","journal-title":"Diabetes Care"},{"issue":"8","key":"1497_CR29","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2337\/dc17-2597","volume":"41","author":"MM McCarthy","year":"2018","unstructured":"McCarthy MM, Grey M (2018) Type 1 diabetes self-management from emerging adulthood through older adulthood. Diabetes Care 41(8):1608\u20131614. https:\/\/doi.org\/10.2337\/dc17-2597","journal-title":"Diabetes Care"},{"key":"1497_CR30","volume-title":"National survey of diabetes care delivery in acute hospitals","author":"M O\u2019Donnell","year":"2018","unstructured":"O\u2019Donnell M, Smyth N, Dinneen S (2018) National survey of diabetes care delivery in acute hospitals. Health Service Executive, Dublin"},{"issue":"4","key":"1497_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.numecd.2017.12.001","volume":"28","author":"G Lepore","year":"2018","unstructured":"Lepore G, Bonfanti R, Bozzetto L et al (2018) Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. Nutr Metab Cardiovasc Dis 28(4):335\u2013342. https:\/\/doi.org\/10.1016\/j.numecd.2017.12.001","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-020-01497-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T01:23:11Z","timestamp":1614648191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-020-01497-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1007\/s00592-020-01497-6","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee of the Royal College of Surgeons in Ireland (RCSI) (Ethics reference no: 1445) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants at the time of completing the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}